TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TWST

Twist Bioscience Corp

Healthcare · Diagnostics & Research

167.00$ +7.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Twist Bioscience Corp (TWST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 118 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TWST
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
67 71 75 81 85 89 93 96 99 104 111 118 432
42 43 44 46 46 46 47 45 48 50 54 56 207
25 29 31 35 38 43 46 51 51 54 57 62 224
24 23 24 22 21 21 24 18 17 17 20 18 72
44 53 56 57 53 56 64 63 57 70 76 81 283
75 76 80 124 74 77 88 81 81 87 96 99 362
-50 -47 -49 -89 -36 -35 -42 -30 -30 -33 -39 -36 -138
0.0 0.0 0.0 0.0 0.0 0.0 0.1
-46 -43 -45 -85 -35 -31 -39 21 -27 -30 -44 -35 -136
-0.2 0.1 0.3 0.2 -0.1 0.1 0.2 0.2 0.3 0.3 0.0 -0.3 0.2
-46 -43 -45 -86 -35 -32 -39 20 -27 -31 -44 -35 -137
-38 -35 -37 -77 -28 -25 -33 26 -21 -27 -32 -28 -108

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?